Hilton Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Sell |
156,075
-818
| -0.5% | -$57.2K | 0.87% | 31 |
|
|
2025
Q1 | $11.5M | Buy |
156,893
+1,576
| +1% | +$116K | 0.98% | 22 |
|
|
2024
Q4 | $10.2M | Sell |
155,317
-20,175
| -11% | -$1.32M | 0.88% | 35 |
|
|
2024
Q3 | $13.7M | Buy |
175,492
+3,921
| +2% | +$305K | 1.06% | 24 |
|
|
2024
Q2 | $13.4M | Sell |
171,571
-31,495
| -16% | -$2.46M | 1.13% | 25 |
|
|
2024
Q1 | $13.8M | Buy |
203,066
+736
| +0.4% | +$49.9K | 1.23% | 20 |
|
|
2023
Q4 | $13.6M | Sell |
202,330
-844
| -0.4% | -$56.8K | 1.46% | 15 |
|
|
2023
Q3 | $13.8M | Sell |
203,174
-10,357
| -5% | -$701K | 1.83% | 12 |
|
|
2023
Q2 | $15.3M | Sell |
213,531
-4,664
| -2% | -$334K | 1.84% | 14 |
|
|
2023
Q1 | $14.8M | Sell |
218,195
-6,690
| -3% | -$454K | 1.94% | 12 |
|
|
2022
Q4 | $12.3M | Hold |
224,885
| – | – | 1.62% | 16 |
|
|
2022
Q3 | $12.3M | Buy |
224,885
+42,865
| +24% | +$2.35M | 1.62% | 16 |
|
|
2022
Q2 | $12M | Buy |
182,020
+27,491
| +18% | +$1.82M | 1.48% | 20 |
|
|
2022
Q1 | $10.3M | Buy |
+154,529
| New | +$10.3M | 1.1% | 38 |
|